Ventripoint Single Ventricle Study

NCT ID: NCT05262907

Last Updated: 2025-10-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-07-08

Study Completion Date

2027-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will validate a coordinate-based 3-dimensional echocardiographic technique for the assessment of cardiac size and function in children and young adults with functional single ventricles.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The accuracy of current echocardiographic techniques for measuring ventricular size and function are limited by geometric assumptions, which are particularly problematic in malformed hearts or functional single ventricles, as well as the inability to visualize the entire heart at one time from a single imaging window, and higher heart rates degrading 3D imaging volume rates. This study will validate a coordinate-based 3-dimensional echocardiographic technique for the assessment of cardiac size and function in children and young adults with functional single ventricles, including a comparison to the gold standard of cardiac MRI.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Congenital Heart Disease Single-ventricle

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Ventripoint 3D Echocardiogram

Ventripoint 3D Echo performed on subject to validate technology for use in single ventricle patients.

Group Type EXPERIMENTAL

Ventripoint Echocardiogram

Intervention Type DEVICE

Non-invasive ultrasound of the heart to evaluate structure and function through 3D imaging.

Transthoracic Echocardiogram or Cardiac MRI

Non-invasive imaging of the heart to evaluate structure and function.

Group Type ACTIVE_COMPARATOR

Transthoracic Echocardiogram or Cardiac MRI

Intervention Type DEVICE

Non-invasive imaging of the heart to evaluate structure and function.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Transthoracic Echocardiogram or Cardiac MRI

Non-invasive imaging of the heart to evaluate structure and function.

Intervention Type DEVICE

Ventripoint Echocardiogram

Non-invasive ultrasound of the heart to evaluate structure and function through 3D imaging.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients with functional single ventricles will be included, regardless of age or surgical palliation stage, who have had or are having a clinically ordered transthoracic echocardiogram and/or cardiac MRI.

Exclusion Criteria

* Patients with congenital heart disease other than functional single ventricles, patients with single ventricle physiology (but not single ventricle anatomy) following a biventricular conversion pathway, or patients unable to understand or consent in English will be excluded.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Duke University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Piers Barker, MD

Role: PRINCIPAL_INVESTIGATOR

Duke University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Duke University

Durham, North Carolina, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Joan Wilson

Role: CONTACT

999999999

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Piers Barker, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Pro00108548

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.